Fundz

Who to call at CellCentric, and when

Fundz watches for the moments CellCentric starts buying, and tells you who to reach.

  • An alert the day CellCentric raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CellCentric, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CellCentric. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Toyota Becomes Equal Partner in Fuel Cell Company Cellcentric Alongside Volvo and Daimler Truck.

Jul 28, 2026

Contract Type

partnership

CambridgeManufacturingBiotechnologyHealth Care

Description

Toyota Motor Corporation has signed a binding partnership agreement to join the fuel cell company Cellcentric, owned by Volvo Group and Daimler Truck. Each company will hold a one-third stake, enhancing collaboration in fuel cell technology and supporting hydrogen ecosystem development.

Quick answer

Toyota Becomes Equal Partner in Fuel Cell Company Cellcentric Alongside Volvo and Daimler Truck. (July 28, 2026). CellCentric is based in Cambridge, England, United Kingdom.

What agreement did CellCentric announce on July 28, 2026?
Toyota Motor Corporation has signed a binding partnership agreement to join the fuel cell company Cellcentric, owned by Volvo Group and Daimler Truck. Each company will hold a one-third stake, enhancing collaboration in fuel cell technology and supporting hydrogen ecosystem development.
What does CellCentric do?
CellCentric is a clinical-stage biotechnology company advancing Inobrodib, a new treatment for cancer, particularly multiple myeloma.
Where is CellCentric based?
CellCentric is based in Cambridge, England, United Kingdom.

Source: Fundz verified event record.

Company Information

Company

CellCentric

Location

Cambridge, England, United Kingdom

About

CellCentric is a clinical-stage biotechnology company advancing Inobrodib, a new treatment for cancer, particularly multiple myeloma. This small molecule drug targets p300/CBP, reducing the expression of key cancer drivers, MYC and IRF4. It is delivered as an oral capsule, allowing patients to use it at home without the need for intensive monitoring. The drug has a favorable safety profile, making it suitable for those unable to access or tolerate other treatment options.

Related People

Will
Likely contact at this company
••••••••@••••••••

See Will's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for CellCentric's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

CellCentric signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.